Search results

39 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
Wan selected to serve on study section for NIH Center for Scientific Review
UNC Lineberger’s Yisong Wan, PhD, has been named a member of the Hypersensitivity Autoimmune and Immune-Mediated Diseases Study Section of the National Institutes of Health’s Center for Scientific Review.
Located in Newsletters / / Honors and Awards / 2018
Phase I clinical trial shows some promise for investigational drug for melanoma
Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.
Located in News
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers led by UNC Lineberger's Hazel Nichols, PhD, analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Located in News
Gene therapy researchers find viral barcode to cross the blood-brain barrier
Scientists led by UNC Lineberger's Aravind Asokan, PhD, reveal how certain gene-carrying AAV vectors can penetrate the brain more efficiently to treat brain and spinal cord conditions, while reducing liver payload.
Located in News
Researchers define structure, function of enzyme key to blood cancers
In the journal Nature, UNC Lineberger's Greg Wang, PhD, and colleagues reported findings about the structure and function of the DNMT3A enzyme complex, which helps control gene expression.
Located in News